The use of the world’s first DNA vaccine, Zykov-D, was approved by the Subject Expert Committee (SEC) of the Drug Administration. This vaccine is unique to India.
The vaccine can be used in adults as well as in adults over 12 years of age. The interval between three doses of this vaccine will be 28 days.
This needleless vaccine was created by Jaidas Cadillac.
Six vaccines were approved in India. Vaccines made by Kovishield, Kovacin, Sputnik V, Mordana and Johnson & Johnson have already received final clearance in India.
On July 1, Jaidas Cadillah applied for approval of their three-dose Zykov-D vaccine.
The Daily Vendor Newspaper learnt that a larger trial of 26,000 volunteers across the country found evidence of 7.8 per cent effectiveness of the vaccine.
The vaccine is also said to be safe for people 12 to 18 years old. It will be possible to bring the vaccine to the market within two months of the clearance fair.
Zydus Cadila has developed the Zykov-D vaccine in collaboration with the Department of Biotechnology and ICMR. Work is underway at the Vaccine Technology Center in Ahmedabad.
The vaccine is kept at a temperature of 2 to 6 degrees centigrade. Can be stored up to three months. The three-dose vaccine has been cleared by the DCGA’s Subject Expert Committee.
Zykov-D will be approved as the second fully home-made vaccine after India Biotech’s Kovacin in Hyderabad. Not only that, the vaccine made by Zydus Cadillac will also set a precedent for the world’s first ‘Plasmid DNA’ vaccine.
Importantly, the Zykov-D vaccine can be given without injecting the needle. The vaccine is specially applied to the area between the skin and the muscles.
Our correspondent gathered that the vaccine is also effective against the Corona Delta variant, the company claims.
In the last 24 hours, 34,456 people have been infected with new corona in the country. Another 365 people died. On the other hand, the number of patients undergoing treatment in the country is the lowest in the last 151 days.
At present 3 lakh 61 thousand 340 patients are under treatment, the country’s health ministry said.